Literature DB >> 7004959

Human pancreatic polypeptide secretion in conditions of exogenous and endogenous hyperglycaemia.

J Marco, J A Hedo, J Castillo-Olivares, M L Villanueva.   

Abstract

The effects of exogenous and endogenous hyperglycaemia on human pancreatic polypeptide secretion have been studied. In normal subjects elevation of plasma glucose concentration by glucose infusion both depressed the basal levels of circulating human pancreatic polypeptide (by 40-50%) and consistently reduced the human pancreatic polypeptide response to the ingestion of a portion-rich meal (areas above pre-meal value: 19.5 +/- 4.1 (mean +/- SEM) vs. 9.6 +/- 2.1, p < 0.01) as well as to caerulein infusion (areas above pre-caerulein value: 8.8 +/- 2.2 vs. 4.6 +/- 1.4, P < 0.01). In diabetic subjects treated with sulphonylureas or diet (fasting plasma glucose: 166 +/- 11 mg/dl, n = 24), human pancreatic polypeptide secretion evoked by food was similar to that of 24 healthy individuals (areas above basal value: 46.6 +/- 9.9 and 33.6 +/- 3.6, respectively). In insulin dependent diabetics (fasting plasma glucose: 231 +/- 19 mg/dl, n = 21) the human pancreatic polypeptide response to the meal (area above basal value: 78.2 +/- 13.7) was significantly greater than that of the controls as well as that of the noninsulin-dependent group (P < 0.05). Since the administration of pancreatic polypeptide to man has been shown to decrease pancreatic exocrine output, postprandial human pancreatic polypeptide hypersection may contribute to the decreased exocrin function of the pancreas often found in insulin-dependent diabetics.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7004959     DOI: 10.1007/bf00281819

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  17 in total

1.  A newly recognized pancreatic polypeptide; plasma levels in health and disease.

Authors:  J C Floyd; S S Fajans; S Pek; R E Chance
Journal:  Recent Prog Horm Res       Date:  1976

2.  Spectrum effects of a new polypeptide (third hormone?) isolated from the chicken pancreas.

Authors:  R L Hazelwood; S D Turner; J R Kimmel; H G Pollock
Journal:  Gen Comp Endocrinol       Date:  1973-12       Impact factor: 2.822

3.  Studies of the distribution of a new avian pancreatic polypeptide and insulin among birds, reptiles, amphibians and mammals.

Authors:  D R Langslow; J R Kimmel; H G Pollock
Journal:  Endocrinology       Date:  1973-09       Impact factor: 4.736

4.  Immunohistochemical localization of human pancreatic polypeptide (HPP) to a population of islet cells.

Authors:  L I Larsson; F Sundler; R Håkanson
Journal:  Cell Tissue Res       Date:  1975       Impact factor: 5.249

5.  Gastric and cephalic stimulation of human pancreatic polypeptide release.

Authors:  I L Taylor; M Feldman; C T Richardson; J H Walsh
Journal:  Gastroenterology       Date:  1978-09       Impact factor: 22.682

6.  Reduced pancreatic polypeptide secretion in obese subjects.

Authors:  J Marco; M A Zulueta; I Correas; M L Villanueva
Journal:  J Clin Endocrinol Metab       Date:  1980-04       Impact factor: 5.958

7.  Islet cell survival determined by morphology. An immunocytochemical study of the islets of Langerhans in juvenile diabetes mellitus.

Authors:  W Gepts; J De Mey
Journal:  Diabetes       Date:  1978       Impact factor: 9.461

8.  Isolation and characterization of a new pancreatic polypeptide hormone.

Authors:  J R Kimmel; L J Hayden; H G Pollock
Journal:  J Biol Chem       Date:  1975-12-25       Impact factor: 5.157

9.  Stimulation of pancreatic polypeptide and glucagon secretion by 2-deoxy-D-glucose in man: evidence for cholinergic mediation.

Authors:  J A Hedo; M L Villanueva; J Marco
Journal:  J Clin Endocrinol Metab       Date:  1978-08       Impact factor: 5.958

10.  Control of pancreatic polypeptide secretion by glucose in man.

Authors:  J Marco; J A Hedo; M L Villanueva
Journal:  J Clin Endocrinol Metab       Date:  1978-01       Impact factor: 5.958

View more
  10 in total

1.  Abnormal ghrelin and pancreatic polypeptide responses in gastroparesis.

Authors:  Kishore V Gaddipati; Hrair P Simonian; Karen M Kresge; Guenther H Boden; Henry P Parkman
Journal:  Dig Dis Sci       Date:  2006-07-26       Impact factor: 3.199

2.  Effect of acute hyperglycaemia on gall bladder contraction induced by cholecystokinin in humans.

Authors:  S Y de Boer; A A Masclee; M C Jebbink; J Schipper; H H Lemkes; J B Jansen; C B Lamers
Journal:  Gut       Date:  1993-08       Impact factor: 23.059

3.  Effect of hyperglycaemia on gallbladder motility in type 1 (insulin-dependent) diabetes mellitus.

Authors:  S Y de Boer; A A Masclee; W F Lam; H H Lemkes; J Schipper; M Fröhlich; J B Jansen; C B Lamers
Journal:  Diabetologia       Date:  1994-01       Impact factor: 10.122

4.  Effects of endogenous and exogenous secretin on plasma pancreatic polypeptide concentrations in dogs.

Authors:  F Koizumi; A Ohkawa; T Kawamura; A Ishimori; I Sasaki; J Kameyama
Journal:  Diabetologia       Date:  1986-04       Impact factor: 10.122

5.  Effect of intravenous glucose on intravenous amino acid-induced gallbladder contraction and CCK secretion.

Authors:  S Y De Boer; A A Masclee; W F Lam; J B Jansen; C B Lamers
Journal:  Dig Dis Sci       Date:  1994-02       Impact factor: 3.199

6.  Cholecystokinin and pancreatic polypeptide release in diabetic patients with and without autonomic neuropathy.

Authors:  B Glasbrenner; E Dominguez-Munoz; R L Riepl; A Vetsi; P Malfertheiner
Journal:  Dig Dis Sci       Date:  1995-02       Impact factor: 3.199

7.  Hyperglycemia modulates gallbladder motility and small intestinal transit time in man.

Authors:  S Y de Boer; A A Masclee; W F lam; J Schipper; J B Jansen; C B Lamers
Journal:  Dig Dis Sci       Date:  1993-12       Impact factor: 3.199

8.  Pancreatic polypeptide response to a protein-rich meal in diabetic patients with and without neuropathy.

Authors:  S Gambardella; M G Felici; B Annibale; G F Delle Fave; F Jacoangeli; V Spallone; G Menzinger
Journal:  J Endocrinol Invest       Date:  1986-02       Impact factor: 4.256

9.  [Effect of caerulein on blood glucose, serum insulin, glucagon, prolactin and growth hormone before and after oral glucose load in healthy volunteers and diabetic patients (author's transl)].

Authors:  R Landgraf; T Eversmann; M M Landgraf-Leurs
Journal:  Klin Wochenschr       Date:  1981-06-01

10.  Influence of blood glucose levels on rat liquid gastric emptying.

Authors:  F Y Chang; S D Lee; G H Yeh; P S Wang
Journal:  Dig Dis Sci       Date:  1996-03       Impact factor: 3.199

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.